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AbstrAct
Objective Measuring the quality of care as experienced 
by patients is increasingly recognised as a way of 
improving healthcare services. However, disease-specific 
measures that take the patient journey into account are 
needed. This paper presents the development of such a 
measure for patients with heart disease and details the 
psychometric evaluation.
Design The questionnaire was developed based on a 
literature review, qualitative interviews and a pilot-test. 
The psychometric evaluation of the measure was assessed 
using exploratory factor analysis (EFA) and confirmatory 
factor analysis (CFA), Cronbach’s alpha coefficient and 
differential item functioning analysis with data from a 
population-based survey.
setting Denmark in 2013–2014.
study participants Nineteen heart patients, four relatives 
and eight health professionals participated in qualitative 
interviews in the development phase, and 15 patients 
participated in the pilot-test. The questionnaire was 
subsequently sent to a random sample of 5000 heart 
patients who were diagnosed in 2013.
results The comprehensive development phase and 
pilot-testing contributed to high content validity of 
the questionnaire. Eligible questionnaire responses 
were received from 2496 patients. EFA indicated a 
nine-factor model: communication at the hospital, 
communication with the general practitioner, information 
on disease and treatment, information on psychosocial 
aspects, rehabilitation/support, organisation, 
medication, involvement of relatives and consideration 
of comorbidity. CFA confirmed the proposed factor 
structure (eg, goodness-of-fit index=0.88, adjusted 
goodness-of-fit index=0.86, root mean square error of 
approximation=0.05), and Cronbach’s alpha coefficient 
revealed good internal consistency of the factors (range: 
0.69–0.93).
conclusions The results suggest that this disease-
specific patient-reported experience measure is of good 
quality when measuring the quality of care among heart 
patients. The inclusion of patients in the development 
phase contributed to high content validity, and subsequent 
psychometric evaluation found high construct validity 
and internal consistency. This measure may be especially 
relevant when seeking information about which aspects 
of care require improvement and the impact on health 
outcomes.
IntrODuctIOn
Due to the impact on daily life and the 
high mortality rates, heart diseases consti-
tute a major public health concern in both 
Denmark and worldwide.1 2 Consideration 
of patients’ experiences are increasingly 
recognised as essential in achieving high 
quality healthcare provision. In early 2000, 
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Research
strengths and limitations of this study
 ► A main strength of this study was the thorough 
psychometric evaluation of the patient-reported 
experience measure.
 ► The survey was nationwide and based on a 
population-based, random sample of 5000 heart 
patients, reducing the risk of selection bias.
 ► The inclusion of a patient journey provides an 
important basis to explore the relationship between 
patients’ experiences with the quality of healthcare 
and long-term health outcomes and to discover 
which aspects of care to address to improve 
patients’ experiences across sectors.
 ► Although this measure could be used in similar 
settings and patient groups, wider generalisation, 
across countries and patient groups, may be 
restricted.
 ► This study is limited by non-responders and item 
non-response.
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the WHO and the Institute of Medicine (IOM) stressed 
the importance of patients’ perspectives for assessing and 
improving healthcare.3 4 WHO introduced the concept 
of responsiveness and IOM identified the provision of 
patient-centred care as one of six objectives for improving 
healthcare. The care should be ‘respectful of and respon-
sive to individual patient preferences, needs and values 
and ensuring that patient values guide all clinical deci-
sions’.4 Accordingly, enhancing patients’ experience with 
the quality of healthcare, which includes aspects such as 
treating patients with dignity and respect and meeting 
the patients information and communication needs5 has 
become a legitimate independent goal for healthcare 
services. Moreover, increasing evidence suggests that 
good experiences are positively associated with clinical 
effectiveness, including adherence to treatment, lower 
length of stay and decreased mortality in various settings 
and patient groups.6–9 
As a result, surveys quantifying patients’ experiences 
with the quality of healthcare have become widespread 
and commonly include patient-reported experience 
measures (PREM).10–12 However, several questions remain 
unanswered. There is no agreement about what consti-
tutes quality of healthcare from the perspective of 
patients, resulting in several multidimensional theoret-
ical frameworks and a range of PREM instruments.10 
According to Beattie et al, the purpose and context 
of the survey is important when choosing the PREM, 
particularly in relation to content validity.10 Also, what 
is important to patients may differ between countries, 
patient groups and healthcare settings, evolving over 
time. Existing instruments have been specific to hospital 
inpatients or outpatients, primary care patients and 
often relate to a single contact. However, to truly repre-
sent the perspective of patients, it can be argued that we 
need to take their experiences with a full patient journey 
into account. This would provide important informa-
tion on which aspects of the care patients feel require 
improvement and provide a unique basis to examine the 
relationship between patients’ experiences and health 
outcomes, such as readmissions and death, including the 
relationship with the single patient experience dimen-
sions. The impact on health outcomes of patients’ expe-
rience with a patient journey across sectors is expected 
to be greater than their experiences with a single consul-
tation or healthcare setting. Information about the 
impact of patients’ experience is scarce, particularly for 
the dimensions of emotional support, coordination of 
care, continuity and transition and involvement of rela-
tives.9 13 Thus, there is a need to develop context-specific 
PREM measures which include a patient journey with 
the perspective of long-term follow-up. The aim of this 
paper was twofold: first, to present the development of 
a national questionnaire measuring patient-reported 
experience of healthcare quality following heart disease, 
covering aspects of the patient journey from first contact 
with the healthcare system to the inpatient and outpa-
tient treatment and rehabilitation and next, to perform 
a psychometric evaluation of a measure covering these 
aspects.
MethOD
study design and setting
The questionnaire development was based on a literature 
review, qualitative focus group interviews and individual 
interviews. It was pilot-tested using cognitive interviewing 
techniques. The psychometric evaluation was assessed 
using exploratory factor analysis (EFA) and confirma-
tory factor analysis (CFA), Cronbach’s alpha coefficient 
and differential item functioning (DIF) analysis with data 
from a population-based survey conducted in Denmark in 
2014. The Danish healthcare system is publicly financed 
with the goal of free and equal access for all 5.6 million 
inhabitants. The Danish health system is divided into two 
sectors: primary healthcare that are provided by general 
practitioners (GPs) and the municipal health services, 
where responsibilities include disease prevention, health 
promotion and rehabilitation outside of the hospital and 
the secondary (hospital) care being responsible for more 
specialised medical treatment (inpatient and outpatient 
care).14
Questionnaire development
The questionnaire was developed between September 
2013 and August 2014. An overview of the stages in the 
development of the questionnaire is available (see online 
supplementary figure 1). We carried out a literature 
review and a qualitative explorative investigation. The 
aim was to develop a context-specific measure with high 
content validity to examine experiences with the Danish 
healthcare system among patients with a heart disease 
and to include the most important measurements of 
their health status. The patient experience measure was 
intended to cover aspects of the patient journey from 
first contact with the healthcare system to the inpatient 
and outpatient treatment and rehabilitation. The litera-
ture search was conducted in the databases PubMed and 
PsycINFO and included reviews (<15 years) and quanti-
tative and qualitative studies (<10 years). The review was 
predefined to include 50–100 articles and the following 
criteria were used to select them: They should cover the 
four heart diseases of interest (ischaemic heart disease, 
atrial fibrillation, heart failure and heart valve disease), 
different topics and different study types. Based on titles, 
300 studies were selected by one researcher (LZ), which 
was reduced by half by another researcher (TH) after 
reading the abstracts. Through a consensus meeting, 
the two researchers agreed on appraisal of 86 studies: 23 
reviews, 29 quantitative studies and 34 qualitative studies. 
We systematically extracted information of each eligible 
paper independently using two data charting forms devel-
oped by LZ and TH, one reporting on the material and 
methods of each study and one reporting the results of 
the studies. The literature review was used as a supple-
ment to the qualitative investigation and as a basis to 
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develop the interview guide. The qualitative investigation 
consisted of three focus group interviews with 19 heart 
patients in total, one focus group interview with four 
relatives of heart patients and eight individual interviews 
with health professionals working with heart patients. 
Patients and relatives were recruited through the Danish 
Heart Foundations’ membership newsletter to which 34 
patients and 8 relatives responded. They were selected 
based on their gender and their address to enable focus 
groups of at least four persons within a reasonable driving 
distance. The Danish Heart Foundations’ counselling 
centre recruited another four patients and two relatives 
to ensure the groups were large enough. The interviews 
were conducted in three different parts of Denmark. The 
patients included 9 men and 10 women with different 
educational background and different heart diseases. 
The relatives included two wives, one husband and a 
daughter of heart patients (further characteristics of the 
participants are available in the online supplementary 
table 1). The health professionals to be interviewed were 
selected to achieve a group representing different health 
professions (eg, physician, nurse, psychologist), health 
sectors (eg, hospital, general practice) and stages of care 
(eg, acute medical treatment, rehabilitation). The inter-
views were conducted at professionals’ work places or as 
telephone interviews. All interviews were conducted by 
LZ and TH. The semistructured interview protocols (see 
online supplementary table 2) were developed through 
discussions in the project group. The group included 
professionals from public health (TH, LZ), anthropology 
(MH), sociology (PJ) and cardiology (AZ). It focused on 
what was perceived by the patients to be important for the 
quality of healthcare, including areas they found prob-
lematic or insufficient and on the challenges they expe-
rienced living with heart disease. The interview protocols 
were modified for patients, relatives and experts, and 
the interviewers were open and flexible so as to include 
any issues the interviewees brought up themselves. The 
focus group interviews lasted approximately 2 hours and 
the individual interviews lasted between 1–1½ hours. 
All interviews were audiorecorded, and by listening to 
these recordings LZ and TH condensed the material, 
meaning that the experiences and opinions expressed 
by the interviewees were provided in a shorter form. 
The analysis conducted by TH and LZ was data-driven 
and guided by conventional thematic analysis strategies 
allowing us to specify major themes and subthemes in 
the material.15 They both read all summaries to get an 
overall impression of the material and identified themes 
and subthemes in each interview (half each). After this, 
they met to discuss, refine and reduce the themes into 
major themes with subthemes. The results of the explor-
atory preinvestigation have been published in Danish 
separately  elsewhere.16
A reference group comprising eight health profes-
sionals participated together in a consensus workshop 
to ensure the questionnaire covered the results from the 
preinvestigation. This process resulted in seven themes 
concerning patient experiences with the quality of care: 
information, communication, organisation, psychosocial 
aspects, rehabilitation/support, medication and involve-
ment of relatives. The group was also consulted to develop 
specific questionnaire items within their area of exper-
tise and review the first version of the questionnaire. The 
reference group comprised the same health professionals 
who took part in the individual interviews, besides three 
replacements who were researchers within the field. We 
used existing Danish patient experience surveys, as inspi-
ration and as a first basis for creating the item wordings of 
PREM.17 The questionnaire was pilot-tested through five 
individual interviews and two focus groups with 10 heart 
patients, based on cognitive interviewing techniques.18 
The questionnaire was further tested by two researchers 
with expertise in constructing surveys. Minor adjustments 
to the questionnaire were made.
the questionnaire
The final questionnaire consisted of 48 PREM items 
covering the seven themes of patient experience with 
the healthcare system identified in the preinvestigation: 
information, communication, organisation, psychosocial 
aspects, rehabilitation/support, medication and involve-
ment of relatives. They covered aspects of the patient 
journey, from first contact with the healthcare system 
to the treatment and rehabilitation in the hospital, 
in the municipality and by the GP. The questions were 
measured on a four-point Likert-type scale from ‘yes, 
to a great degree’ to ‘no, not at all’, though a few ques-
tions were binary (yes/no). Further reply options were 
‘do not know’ and ‘not relevant’ (primarily managed 
by filter questions ‘if you answered…, go to question.’). 
Besides this, the questionnaire also included measures 
of health status, including physical status, emotional 
status, anxiety and depression, sexual health, quality of 
life, overall health and adherence to medication. This 
information uncovers patient’s needs and provides infor-
mation on whether healthcare goals have been achieved 
as most healthcare goals relate to improvement in these 
areas, besides basic survival.19 Patient characteristic items 
including measures of patient activation/engagement, 
decision-making preferences, comorbidity, education 
and employment status were also included. This informa-
tion was primarily measured by internationally validated 
questionnaire scales. An overview of the full content of 
the questionnaire which took approximately 30–45 min 
to answer is available (see online supplementary table 3) 
and the original version is available online.20
sample
A random population-based sample of 5000 patients 
diagnosed with incident ischaemic heart disease, atrial 
fibrillation, heart failure or heart valve surgery in 2013 
was selected from the Danish National Patient Register 
(NPR). NPR includes information on all inpatient and 
outpatient contacts in all public and private Danish hospi-
tals.21 Disproportionate stratified random sampling was 
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used to reach at least 400 respondents for each of the four 
diagnostic groups (taking previous response percentages 
among heart patients into account) in order to ensure 
that results could be presented for each group within 
reasonable resources. The sampling was based on the 
incidences of disease in Denmark in 2012. Patients were 
included if they had none of the specified heart diseases 
in the previous 5 years (2008–2012), were ≥35 years, 
Danish residents and alive. They were selected based on 
their diagnosis at discharge according to ICD-10 codes, 
except for heart valve patients, who were identified using 
surgical codes according to the Danish version of the 
Nordic Classification of Surgical Procedures (NCSP-D).22 
If they had more than one heart disease in 2013, they 
were selected based on their first contact. The sample 
consisted of 2116 patients with ischaemic heart disease 
(ICD-10: I20, I21, I23, I24,I25), 1695 patients with atrial 
fibrillation (ICD-10: I48), 642 patients with heart failure 
(ICD-10: I11.0, I13.0, I13.2, I42.0, I150) and 547 patients 
who had undergone heart valve surgery (NCSP-D: 
KFG, KFK, KFM, KFJE, KFJF) (these four diagnoses are 
referred to as patient groups). The selection criteria were 
established in consultation with two cardiologists (AZ and 
the research director at the Danish Heart Foundation) 
and based on former register-based studies within cardio-
vascular diseases.23 24 Further information is available in 
(see online supplementary table 4).
Data collection
The survey was conducted from October to December 
2014. A paper questionnaire, a covering letter and a 
prepaid return envelope were posted to the patient 
sample group. The questionnaire could be completed 
on paper or online by using a unique password. If no 
response was received after 2 weeks, another question-
naire was sent and after 4 weeks they were contacted by 
telephone. Addresses were obtained from the Danish 
Civil Registration System (CRS) with information about 
all persons with a residence in Denmark, including name, 
date of birth, place of birth, place of residence and so 
on,25 and the company NN Markedsdata linked publicly 
available phones numbers to addresses.
statistical analysis
Sociodemographic characteristics of respondents and 
non-respondents were compared according to gender, 
age (at diagnosis), diagnosis, education, income, region, 
civil status, ethnic background and time from diagnosis 
to the distribution of questionnaires to examine whether 
the non-respondents deviated from the respondents. 
School and business education was combined into a 
single measure, according to the International Standard 
Classification of Education.26 Average disposable income 
(after tax and interests) was calculated for the period 
2008–2012 (100 DKK=13.44 EUR). Ethnic background 
was based on Statistics Denmark classification: persons of 
Danish origin (people born in Denmark with at least one 
Danish-born parent with Danish citizenship), immigrants 
(people born abroad with no Danish-born parents with 
Danish citizenship) and descendants (people born in 
Denmark with no Danish-born parents and without 
Danish citizenship). The information was obtained from 
CRS, NPR, the Population’s Education Register and the 
Income Statistics Register.27
We conducted factor analysis to explore if our data 
measured the dimensions (factors) identified in the 
preinvestigation (construct validity). EFA was used as 
preliminary analysis to explore the structure of rela-
tionships between the items using both varimax rota-
tion (orthogonal) and promax rotation (oblique). 
A priori, seven factors were identified. We expected 
their respective items to have relatively high loadings 
on their specific factor and low loadings on other 
factors. A few items could theoretically enter more 
than one of the predefined factors and EFA provided 
insight into which factor was the best fit. To assess 
whether data were appropriate for factor analysis, the 
Kaiser-Meier-Olkin measure of sampling adequacy was 
used and a value above 0.6 is considered tolerable.28 
To extract factors, we used the eigenvalue-great-
er-than-one rule, the scree plot and the proportion 
of variance accounted for. Further, the items that 
load on a factor should share a conceptual meaning 
and the items that load on different factors should 
appear to measure different constructs.28 Items were 
excluded when EFA showed low factor loadings (<0.4) 
and when Cronbach’s alpha increased markedly 
without the item. Cronbach’s alpha measures internal 
consistency (reliability) with a coefficient ≥0.7 consid-
ered to be good.29 Each dimension was also analysed 
separately, pairwise and so on, and ‘do not know’ 
responses were recoded to ‘no, not at all’ in a sensi-
tivity analysis of the full model to allow most valid data 
to be used. The primary investigator (LZ) and a stat-
istician (AKE) together compared the results from all 
sensitivity analyses with the main analyses and evalu-
ated whether they pointed in the same direction.
To confirm the proposed factor structure by the EFA, 
CFA was performed. The overall adequacy of fit for the 
model was evaluated using a χ² test describing the similarity 
of the observed and expected matrices and by a number 
of goodness-of-fit indices: the goodness-of-fit index (GFI) 
with values>0.90 indicating a good model fit, the adjusted 
(for df) goodness-of fit index (AGFI) with values>0.80 
indicating a good model fit, the standardised root mean 
square residual (SRMR) with a cut-off value close to 0.08, 
the root mean square error of approximation (RMSEA) 
with a small value indicating better model fit, typically 0.06 
or less and the comparative fit index (CFI) with a larger 
CFI value indicating better model fit, typically 0.95 or 
greater.28 30 Nevertheless, the cut-off values are arbitrary but 
the measurements together provide a solid basis to evaluate 
the model fit. To include respondents with missing values, 
we used the full information maximum likelihood (FIML) 
method, which is suggested to be the most appropriate way 
to handle missing data in CFA.31 As a sensitivity analysis, we 
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Figure 1 Flow diagram of the process from the sample to the final study population.
performed complete case analyses using the method ML 
and robust ML, the latter being robust to non-normality. 
Furthermore, ‘do not know’ responses were recoded to 
missing in an additional FIML analysis (otherwise ‘do not 
know’ responses were excluded). Finally, we excluded the 
largest patient group (ischaemic heart disease) from the 
main analysis.
Differential item functioning (DIF) (both uniform and 
non-uniform) was examined to evaluate whether men 
versus women and patients with ischaemic heart disease 
versus the three other patient groups respond differently to 
the measurement items using ordinal logistic regression,32 
for example, if men and women responded differently to 
the item ‘Do you feel informed about how the disease may 
affect your future?’ after accounting for their overall level 
of information (uniform DIF) and if the direction of the 
difference changed as their overall level of information 
changed (non-uniform DIF). The likelihood ratio test was 
used to compare the goodness-of-fit of the models (with 
and without DIF). A significance level of 0.01 was used 
because the large number of significance tests increases the 
risk of type 1 error and the large sample size increases the 
risk of detecting unimportant, but statistically significant 
DIF.32 When DIF was statistical significant, the measure of 
effect size R2 was used to evaluate the clinical or practical 
significance using an R2 difference cut-off level of 0.02.32
Data were analysed using SAS V.9.3 (SAS Institute, Cary, 
North Carolina, USA).
ethics
The survey with individual-linked information to regis-
tries is approved by the University of Southern Denmark 
(2015-57-0008, no. 17/329 and 17/8592) according to 
the Permission of the Danish Data Protection Agency. 
All participants were informed about the aim of the 
study and were assured that participation was voluntary 
and results would be anonymised. Verbal consent was 
obtained from individuals participating in the interviews, 
and consent was assumed for survey participants when 
they returned the questionnaire. This type of study does 
not require further formal ethical approval, according 
to Danish law.27 33 The method of surveying a sample 
identified in NPR entails ethical considerations. Some of 
the selected heart patients may not recognise their own 
condition, especially patients with asymptomatic atrial 
fibrillation, due to the character of the disease. Further-
more, register information is not always erased, even if 
subsequent examinations show that the patient does not 
have the disease. This can be due to administrative errors. 
We, therefore, informed all patients that they had been 
selected to receive a questionnaire because, according to 
register information, they had been examined/treated 
for a heart disease in 2013. Each patient was also asked 
whether they had been diagnosed with a heart disease. If 
not, they were asked to return the questionnaire without 
answering further questions.
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Table 1 Sociodemographic characteristics of the respondents and non-respondents
Respondents Non-respondents
Source of information(n=2496) (n=1971)
Gender, women, % 35.3 42.8 CRS
Age (at diagnosis), mean years (25th/75th 
percentile)
68.7 (62.1/76.4) 69.3 (59.0/80.6) CRS
Diagnosis, % NPR
  Ischaemic heart disease 43.4 41.3
  Atrial fibrillation 30.3 36.1
  Heart failure 10.6 15.2
  Heart valve disease 15.7 7.5
Civil status, % CRS
  Married 64.2 48.1
  Widow/widower 16.3 23.5
  Divorced 12.0 16.7
  Unmarried 7.5 11.7
Educational level, % PER
  Basic school 36.2 47.1
  Upper secondary or vocational school 41.9 37.1
  Higher education 21.9 15.9
Income, EUR, mean (25th/75th percentile) 27,596 (17,597/32,493) 24,744 (16.389/27,763) ISR
Ethnic background, % CRS
  Danish origin 94.7 91.8
  Immigrant 5.1 7.9
  Descendant 0.2 0.3
Region, % CRS
  Capital Region of Denmark 25.2 31.4
  Central Denmark Region 22.8 20.4
  North Denmark Region 10.5 10.0
  Region of Southern Denmark 24.0 23.5
  Region Zealand 17.5 14.8
Time from diagnosis to distribution of 
questionnaires, Months*, mean (25th/75th 
percentile)
16.3 (13.1/19.6) 16.5 (13.3/19.8) NPR
*Standard month=30 days.
CRS, The Danish Civil Registration System; ISR, The Income Statistics Register; NPR, The Danish National Patient Register; PER, The 
Population’s Education Register.27
results
study population
The questionnaire was returned by 3029 patients (61% of 
the invited population). Of these, 533 stated they did not 
have a heart disease in 2013, and they were excluded from 
the sample (adjusted sample 4467). A total of 2496 patients 
were eligible for inclusion (56%) (see figure 1). A total of 
43% of the respondents had ischaemic heart disease, 11% 
heart failure, 30% atrial fibrillation and 16% had under-
gone heart valve surgery and 35% of the patients were 
women. Sociodemographic characteristics of the respon-
dents are shown in table 1.
non-respondents analyses
The respondents differed from the non-respondents 
according to sociodemographic characteristics (table 1). 
Patients who were either male, married, had a heart valve 
disease or a higher education seemed to be over-represented 
in the response group. The difference in percentage points 
was below 10, with more than half below five (civil status 
‘married’ did however have a 16.1 points difference and 
educational level ‘basic school’ a 10.9 points difference).
Validation of the PreM measurement
The predefined PREM dimensions from the preinvesti-
gation, their items, responses and proportion of missing 
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values are presented in table 2. The mean item-non-re-
sponse was 12.1%.
Based on an overall picture of several analyses all 
pointing in the same direction (including subanalyses 
and sensitivity analyses) the EFA provided support for the 
predefined dimensions. The exceptions to this were the 
dimension ‘communication’ that was split in two and the 
dimension ‘consideration of comorbidity’ was found to 
be an independent dimension separated from ‘organisa-
tion’. Thus, it resulted in a nine-factor model: (1) commu-
nication at the hospital, (2) communication with the GP, 
(3) information on disease and treatment, (4) informa-
tion on psychosocial aspects, (5) rehabilitation/support, 
(6) organisation, (7) medication, (8) involvement of rela-
tives and (9) consideration of comorbidity, with a total of 
41 items. Four items (E2, E5, B7, D5) were found to fit 
another dimension, rather than their predefined dimen-
sion, and seven items (A1, B6, D6, E1, E8, E9, F1) were 
excluded because they did not load substantially on any 
factors. Item E3 ‘Do you think a doctor or a nurse at the 
hospital have had an overview of the course of treatment 
of your heart disease at all times?’ was the only item with 
cross-loading. Based on theoretical considerations, it was 
placed within the dimension ‘organisation’ although it 
also loaded onto the dimension ‘communication at the 
hospital’. When the final nine dimensions were anal-
ysed separately, to allow most valid data to be used, EFA 
suggested one factor for each of them. The factor load-
ings were between 0.49 and 0.95, and the dimensions 
revealed good internal consistency with Cronbach’s 
alpha coefficients ranging from 0.69 to 0.93 (table 3). 
Results with all dimensions analysed simultaneously using 
promax rotation are presented in the online supplemen-
tary table 5. The results were similar regardless of rotation 
type (promax/varimax).
The CFA supported the nine-factor model because it 
provided an acceptable overall fit: GFI=0.88, AGFI=0.86 
SRMR=0.06, RMSEA=0.05 and CFI=0.93. The χ² test 
did though indicate a poor fit (p<0.001), but this test 
is limited by its sensitivity to sample size and model 
complexity. Thus, the model was expected to be 
rejected because of our large sample size and complex 
model, and therefore more emphasis was put on the 
other fit indices. The correlation between the factors 
(range=0.02–0.80, 54% below 0.50), the factor loadings 
for each item (range=0.43–0.95, 75% above 0.6) and the 
proportion of the variance for each item that could be 
explained by the factor (range=0.19–0.90, 58% above 
0.50) are detailed in figure 2. All the sensitivity analyses 
confirmed the results. Statistical significant uniform DIF 
was detected in two items for gender (A2 and B1), for 
patient groups in four items (B3, B4, C3 and D5) and 
non-uniform DIF in one item (F3). Importantly, none 
of the effect sizes were clinical significant. The full text 
of the final nine-factor model with 41 items constituting 
the patient-reported instrument that measures experi-
ences of healthcare quality in Denmark are available in 
the online supplementary table 6.
DIscussIOn
This study conducted a psychometric evaluation of a 
national questionnaire measuring patient-reported expe-
rience with the quality of patient care following a heart 
disease, covering aspects of the patient journey from first 
contact with the healthcare system to the inpatient and 
outpatient treatment and rehabilitation and presented 
the development of the questionnaire. The results suggest 
that the instrument is of good quality. The inclusion of 
heart patients in the comprehensive development phase 
and pilot testing of the questionnaire contributed to high 
content validity, and the subsequent psychometric evalu-
ation found high construct validity and internal consis-
tency. EFA indicated a nine-factor model: communication 
at the hospital, communication with the GP, information 
on disease and treatment, information on psychosocial 
aspects, rehabilitation/support, organisation, medi-
cation, involvement of relatives and consideration of 
comorbidity with a total of 41 items, and CFA confirmed 
this structure provided a good fit to the data suggesting 
high construct validity. Furthermore, Cronbach’s alpha 
coefficient revealed good internal consistency of the 
dimensions, and no clinical significant DIF was detected.
Some challenges regarding the measure were observed. 
CFA suggested that the factors organisation and commu-
nication at the hospital were highly overlapping as 
the correlation between the factors was 0.80. A factor 
correlation that exceeds 0.80 or 0.85 is often used as 
the criterion to define poor discriminant validity.31 We 
kept the factors separated, because they are conceptu-
ally different, another issue important to consider before 
collapsing factors.31 In future, it may be valuable to refine 
or expand the questions intended to capture the dimen-
sion organisation. The mean item-non-response was 
12.1%, indicating a reasonable acceptance of the ques-
tionnaire. Even so, the question on smoking cessation 
guidance, if side-effects were taken seriously and the two 
questions regarding consideration of comorbidity had a 
proportion of missing values above 20%. These questions 
were irrelevant for a large proportion of the respondents 
and they might have skipped them without noticing the 
‘not relevant’ response option. Simple filter questions 
may work better. The high proportion of ‘do not apply 
to me responses’ in certain items indicates a challenge 
with developing questionnaires to a wide group of heart 
patients. We chose to maintain such items to ensure that 
all aspects of importance to heart patients are repre-
sented in the questionnaire.
Implications
We believe this is the first PREM instrument among heart 
patients, covering aspects of the patient journey from first 
contact with the healthcare system to the inpatient and 
outpatient treatment and rehabilitation. This makes it 
particularly relevant when seeking information on aspects 
of care requiring improvement and when exploring long-
term health outcomes. This new measure and the possi-
bility of linking individual level patient data from Danish 
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Figure 2 Results from the confirmatory factor analysis , using the full information maximum likelihood method. N=814; 
χ2=15674, p=<0.0001; GFI=0.88; AGFI=0.86; CFI=0.93; RMSEA=0.05; SRMR=0.06. *N=507; χ2=12531, p=<0.001; GFI=0.87; 
AGFI=0.85; CFI=0.93; RMSEA=0.05; SRMR=0.06. *Complete case analysis, using the robust maximum likelihood method. 
Abbreviations: AGFI, the adjusted goodness-of fit index; CFI, comparative fit index; GFI, goodness-of-fit index; GP, general 
practitioner; RMSEA, root mean square error of approximation; SRMR, standardised root mean square residual. Note: The 
coefficients associated to the left are the correlations between the latent factors. The coefficients associated with arrows 
leading from the latent factors to the item products show the factor loadings for each item product. The coefficients to the 
right of the item products are the proportion of the variance for the item product that could be explained by the latent factor. 
n/a: Items excluded from the analysis, because they were irrelevant for a large proportion of respondents, reducing the data 
substantial: C1, E7, F5 and the factor consideration to comorbidity (E10 and E11). Subanalyses and sensitivity analyses 
supported the inclusion of these items.
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registries would allow future follow-up studies to examine 
the relationship between patients’ experiences with the 
quality of care and health outcomes such as readmis-
sions and mortality. The measure would also be a suitable 
national surveillance tool to track performance of the 
healthcare system over time, as seen from the perspec-
tive of patients with heart disease. However, in acknowl-
edging that what is important to patients may shift over 
time,10 we suggest refining the measurement on a regular 
basis. The measure is not appropriate for benchmarking 
hospital performance because several questions span 
across different sectors. Other measures are available for 
this purpose.10
strengths and limitations
A main strength of this study was the thorough psycho-
metric evaluation of the measure, which was based on a 
large population-based random sample of patients with 
heart disease limiting introduction of selection bias. 
However, a number of limitations should be considered. 
Missing-item non-response, ‘do not know’ and ‘do not 
apply to me’ responses reduced the number of valid 
responses and the data for the factor analysis substan-
tially, even though the numerous subanalysis and sensi-
tivity analysis all confirmed the results. The results of this 
study may not be generalisable to other patient groups; 
including patients with heart diseases other than those 
included in this study, patients below 35 years of age 
and patients only treated at their GP, since these patient 
groups are not represented in the survey. Nevertheless, it 
included the four most common heart diseases and the 
age groups where heart disease is most frequent.
Only half of the invited patients completed the survey, 
which is in accordance with other patient experience 
surveys,12 34 and the small differences between non-re-
spondents and respondents indicate only minor impli-
cations. Also, no noteworthy differences were found 
according to age, educational level and region when 
comparing the respondents to the total population 
of heart patients (new cases in 2013),35 although men 
were over-represented (data not shown). The respon-
dents were diagnosed between 10 and 22 months prior 
to the data collection and the delay might make it diffi-
cult for patients to remember their first encounters with 
the healthcare system, but it might also help to distin-
guish between minor irritations and more serious fail-
ings.5 Importantly, it allows for the inclusion of a patient 
journey from first contact with the healthcare system to 
the inpatient and outpatient treatment and rehabilita-
tion. Also, the variation in time since diagnosis may have 
influenced the patients’ answers. To our knowledge, no 
studies have considered the possible effects of time on 
PREM. The instrument is developed among relatively 
newly diagnosed patients, and even though the instru-
ment is developed to cover aspects of the patient journey, 
it does only give an indication of their experience until 
that point in time. Nevertheless, as long as it is possible 
to identify and specify which course of disease is under 
consideration, we believe the questionnaire can be used 
by anybody with a heart disease. However, this assumption 
has not been tested. This measure is recommended for 
similar settings and patient groups; however, wider gener-
alisation across countries may be restricted due to differ-
ences in the organisation of healthcare systems and so on. 
Moreover, generalisation to other patient groups must be 
done with caution, because what is important to diverse 
patient groups may differ.10 Also, we acknowledge the 
importance of conducting qualitative studies to comple-
ment patient experience surveys and vice versa.
cOnclusIOn
The results suggest that the developed PREM is of good 
quality for measuring the quality of care among patients 
with heart disease covering aspects of the patient journey 
from first contact with the healthcare system to the inpa-
tient and outpatient treatment and rehabilitation. The 
involvement of heart patients in the development phase 
contributed to high content validity, and subsequent 
psychometric evaluation found high construct validity 
and internal consistency. The inclusion of a patient 
journey provides an important basis on which to explore 
the relationship between patients’ experiences with the 
quality of healthcare and long-term health outcomes 
and which aspects of care to address to improve patients’ 
experiences.
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